Sweden

EU reportly seeks 10 million AstraZenca vaccines from India

Thu, 2021-04-01 10:55 — mike kraft

Exclusive: EU seeks 10 million AstraZeneca vaccines from India to meet shortfall - Indian source The European Union has asked India to allow it to buy 10 million doses of AstraZeneca's COVID-19 vaccine from Serum Institute of India, a government official told Reuters, the latest sign of growing pressure on Delhi to export more of its production to other countries. Neha Arora U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU reportly seeks 10 million AstraZenca vaccines from India
Log in or register to post comments

Analysis: Overview of the AstraZeneca vaccine and clots issue --AP

Wed, 2021-03-31 12:38 — mike kraft

EXPLAINER: What we know about AstraZeneca blood clot reports LONDON (AP) — German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under 60 after more unusual blood clots were reported in a small number of people who... AP NEWS

LONDON (AP) — German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under 60 after more unusual blood clots were reported in a small number of people who received the shots.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Analysis: Overview of the AstraZeneca vaccine and clots issue --AP
Log in or register to post comments

New statement: AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results

Wed, 2021-03-24 22:07 — mike kraft

After results are questioned, AstraZeneca says complete data shows its vaccine is still highly effective.

https://www.nytimes.com/live/2021/03/24/world/covid-vaccine-coronavirus-cases#after-results-are-questioned-astrazeneca-says-complete-data-shows-its-vaccine-is-still-highly-effective

AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday.

The company said in a news release that its vaccine was 76 percent effective at preventing Covid-19. That is slightly lower than the efficacy number that the company announced earlier this week.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about New statement: AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results
Log in or register to post comments

Benefits of AstraZeneca vaccine outweigh any rare reactions, WHO chief scientist says

Wed, 2021-03-24 19:36 — mike kraft

Benefits of AstraZeneca vaccine outweigh any rare reactions, WHO chief scientist says Reports of extremely rare blood clots should not deter governments from distributing the AstraZeneca vaccine to their citizens, according to the World Health Organization’s Chief Scientists Soumya Swaminathan. By <a href="/profiles/julia-hollingsworth">Julia Hollingsworth</a>, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Benefits of AstraZeneca vaccine outweigh any rare reactions, WHO chief scientist says
Log in or register to post comments

U.S. health officials and an oversight board accused AstraZeneca of presenting potentially misleading information

Tue, 2021-03-23 15:57 — mike kraft

Federal health officials and an independent oversight board accused AstraZeneca of presenting the world with potentially misleading information about the effectiveness of the company’s Covid-19 vaccine, an extraordinary blow to the credibility of a company whose product has been seen as critical to the global fight against the pandemic.

In a two-page letter to AstraZeneca and federal authorities on Monday, an independent panel of medical experts that was helping oversee the vaccine’s clinical trial in the United States said the company had essentially cherry-picked data that was “most favorable for the study as opposed to the most recent and most complete.”

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

AstraZeneca commits to releasing more complete vaccine data after concerns from NIH

Tue, 2021-03-23 10:05 — mike kraft

https://news.yahoo.com/astrazeneca-commits-releasing-more-complete-122835190.html

AstraZeneca acknowledged on Tuesday morning that a press release about its U.S. coronavirus vaccine trial was based on data through Feb. 17, and promised to release more complete results that are "consistent with" the interim data within the next 48 hours.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca commits to releasing more complete vaccine data after concerns from NIH
Log in or register to post comments

AstraZeneca vaccine protects fully against Covid-19’s worst outcomes, new study shows.

Mon, 2021-03-22 09:16 — mike kraft

AstraZeneca: US data shows vaccine effective for all ages LONDON (AP) — AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease across all age groups in a late-stage study in... AP NEWS

LONDON (AP) — AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease across all age groups in a late-stage study in the United States, the company announced Monday.

Country / Region Tags:

General Topic Tags: